Levetiracetam Tablet
Product Images NDC 87063-192

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 87063-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 (Label 1000mg)

FDA Label Image

250 (Label 250mg)

This text appears to be related to pharmaceutical packaging details for Levetiracetam tablets in various quantities and strengths. The text includes information such as National Drug Code (NDC), quantity, manufacturing details, lot numbers, drug status (RX), storage instructions, and other related information. The tablets are indicated for prescription use.*

FDA Label Image

500 (Label 500mg)

FDA Label Image

750 (Label 750mg)

This text appears to be an excerpt from pharmaceutical product labels for Levetiracetam Tablets, USP 750 mg, manufactured by Cranbury Pharmaceutics. The tablets are described as scored and debossed with the marking X 1015. The suggested use is 750 mg. The tablets come in various quantities ranging from 30 to 120 tablets. It is recommended to store the medication at 20-25 degrees Celsius. The text also includes information about the National Drug Code (NDC) and batch numbers for the different quantities of tablets.*

FDA Label Image

Structure Formula (Levetiracetam Tablets 1)

FDA Label Image

Figure1 (Levetiracetam Tablets 2)

This text provides information about the percentages of patients in a study receiving different dosages of Levetiracetam compared to a Placebo. The data shows that 9% of patients were part of the study, with various percentages receiving either 1000mg/day or 3000mg/day of Levetiracetam, and a placebo group consisting of 95 patients.*

FDA Label Image

Figure2 (Levetiracetam Tablets 3)

This is a statistical report showing the percentage of patients in different treatment groups. The data includes the percentage of patients in each group, such as 63% and 35.2%. The data also includes the number of patients in each group, like 111 patients in the placebo group and 105 patients in the levetiracetam 2000 mg/day group. The report seems to provide information related to a clinical trial or medical study.*

FDA Label Image

Figure3 (Levetiracetam Tablets 4)

FDA Label Image

Figure4 (Levetiracetam Tablets 5)

This is a statistical data table showing percentages for different categories. It includes information on two groups: Placebo (N=97) and Levetiracetam (N=101). The data seems to be related to some kind of study or experiment.*

FDA Label Image

Figure5 (Levetiracetam Tablets 6)

FDA Label Image

Figure6 (Levetiracetam Tablets 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.